MED-EL unveils SONNET 3: The next generation in hearing technology for ultimate in user experiences

September 20, 2024 – (Innsbruck, Austria): MED-EL, a global a leader in hearing implant solutions, is excited to announce the launch of SONNET 3, the latest innovation in behind-the-ear (BTE) audio processors for cochlear implant users. Designed to deliver exceptional hearing performance and seamless connectivity, SONNET 3 integrates cutting-edge technology to enhance hearing experiences and fit seamlessly into everyday life.

• SONNET 3 offers exceptional sound quality, integrated wireless connectivity, and optimized for bilateral use
• Designed for user convenience with advanced digital features and robust waterproof housing for everyday reliability
• Direct streaming from Android and iOS devices enhances user accessibility

“SONNET 3 represents a significant step forward in hearing technology,” says Jennifer Robinson, Corporate Director of Product Management Hearing Solutions at MED-EL. “Our unwavering commitment to enhancing users' quality of life is embodied in SONNET 3’s advanced, user-centric design and digital features. This device ensures that our users enjoy exceptional comfort and sound clarity in all their listening experiences.” Built on the successful SONNET platform, SONNET 3 is MED-EL’s smallest and lightest behind-the-ear (BTE) audio processor. It offers a more compact and unobtrusive fit, weighing only 9.5 grams and making it more than a gram lighter than its predecessor, SONNET 2. This reduction represents a remarkable achievement for such a small device. SONNET 3 includes advanced streaming options, a flexible silicone earhook for all-day comfort, and an intuitive touch key for easy control, allowing users to switch the processor to standby mode or change programs quickly. 

SONNET 3 sets a new standard in auditory innovation with its innovative features designed to enhance user experience and connectivity: 

Exceptional sound quality: SONNET 3 integrates Automatic Sound Management (ASM) 3.0 Adaptive Intelligence, advanced noise reduction, microphone directionality, and FineHearing sound coding. ASM 3.0 automatically adjusts settings in real-time to optimize hearing in various environments, while FineHearing delivers a richer and more natural sound by preserving the fine details of speech and music. These features provide users with a clear and natural auditory experience, ensuring they stay connected with the world around them.

Integrated wireless connectivity: With direct wireless streaming, SONNET 3 connects effortlessly to both Android and iOS devices. Users can stream music, phone calls, and other audio sources directly to their processor, enhancing convenience and usability without the need for additional devices.

Waterproofing* and durability: With an IP68 rating, the SONNET 3 is designed to withstand daily exposure to moisture, sweat, and dust. Users can engage in their daily activities without worrying about damaging their processor, ensuring reliable performance in various environments.

Optimized for bilateral use: For users with two cochlear implants, the MAESTRO software automatically assigns Bluetooth-IDs to each SONNET 3 audio processor. Once paired, the devices can stream audio in sync to both ears, creating a balanced and immersive auditory experience.

Enhanced digital features: SONNET 3 comes with enhanced digital features designed to improve user experience and convenience. The AudioKey app allows users to control their processor, locate it if lost, and monitor its status from their smartphone. With the Guardian Role feature, the hearing and audio processor settings of a child or a person being cared for can be monitored and managed directly from a phone. MED-EL is the only manufacturer offering this function, ensuring optimal use of the audio processor. 

“SONNET 3 is designed to provide our users with their ultimate hearing experience,” emphasizes Jennifer Robinson. “It seamlessly integrates into everyday life, empowering users to connect with loved ones, engage fully in their favorite activities, and enjoy exceptional sound quality.”

For more information about SONNET 3 and other MED-EL hearing solutions, please visit www.medel.com.

*IP68 rating: Waterproof for immersion in water up to a maximum depth of 1 meter for 60 minutes

About MED-EL

MED-EL Medical Electronics, a leader in implantable hearing solutions, is driven by a mission to overcome hearing loss as a barrier to communication and quality of life. The Austrian-based, privately owned business was co-founded by industry pioneers Ingeborg and Erwin Hochmair, whose ground-breaking research led to the development of the world’s first micro-electronic multi-channel cochlear implant (CI), which was successfully implanted in 1977 and was the basis for what is known as the modern CI today. This laid the foundation for the successful growth of the company in 1990, when they hired their first employees. To date, MED-EL has more than 2,800 employees from around 80 nations and 30 locations worldwide.
The company offers the widest range of implantable and non-implantable solutions to treat all types of hearing loss, enabling people in 137 countries enjoy the gift of hearing with the help of a MED-EL device. MED-EL’s hearing solutions include cochlear and middle ear implant systems, a combined electric acoustic stimulation hearing implant system, auditory brainstem implants as well as surgical and non-surgical bone conduction devices. www.medel.com   

CEO

Doz. DI Dr DDr med. h.c. Ingeborg Hochmair

Press Contact

PR & Corporate Communications
MED-EL Medical Electronics
Fürstenweg 77a
6020 Innsbruck
Austria
T: +43 5 7788
E: [email protected]